Clinical Trials
23 trialsTissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
SELECT-NK-THYM
Beijing Biotech
PT-112 in Subjects With Thymoma and Thymic Carcinoma
National Institutes of Health Clinical Center (CC)
Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
Fudan University
Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
Fudan University
HEARTS Trial for Thoracic Cancers
University of Wisconsin, Madison
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
M.D. Anderson Cancer Center
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Georgetown University
Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma
The First Affiliated Hospital with Nanjing Medical University
IMMUNORARE5
Hospices Civils de Lyon
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Chongqing Precision Biotech Co., Ltd
Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors
Shanghai Proton and Heavy Ion Center
Molecular Analysis and Treatment Options of Thymic Malignancies
Shanghai Chest Hospital
SPRATS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
Sun Yat-sen University
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Xiangya Hospital of Central South University
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
Assiut University
INTHYM
Erasmus Medical Center
Robot-assisted vs VATS for Thymoma
Shanghai Pulmonary Hospital, Shanghai, China
Artemis
National Cancer Center, Japan
PROTHYM
Swedish Lung Cancer Study Group